Laura Eichorn is a founding employee of Imago BioSciences, Inc. She brings to the team over 25 years of operational experience. As Imago’s Chief Operating Officer and Interim Chief Financial Officer, Ms. Eichorn manages finance, legal, human resources, communications and marketing-related activities.
Prior to joining Imago BioSciences, Ms. Eichorn was Vice President of Operations and Finance at FerroKin BioSciences, Inc., beginning as a founding employee in 2007 through the FerroKin acquisition in April 2012 by Shire Pharmaceuticals.
Ms. Eichorn began her career at New Enterprise Associates in Baltimore, MD in 1995. She went on to establish a US office for UK-based Abingworth Venture Management in 1997. She then went to work at DNA Sciences followed by DataHooks, Inc., both in the San Francisco Bay area. She has a Bachelor of Arts degree from Frostburg State University in international studies.